Skip to content

Remdesivir

Veklury (remdesivir) is a small molecule pharmaceutical. Remdesivir was first approved as Veklury on 2020-07-03. It is used to treat coronavirus and virus diseases in the USA. It has been approved in Europe to treat coronavirus infections. It is known to target ORF1a polyprotein;ORF1ab polyprotein, RNA-dependent RNA polymerase, and Replicase polyprotein 1ab. Veklury's patents are valid until 2038-07-10 (FDA).
Trade Name Veklury
Common Name Remdesivir
ChEMBL ID CHEMBL4065616
Indication coronavirus, coronavirus infections, virus diseases
Drug Class Antivirals: adenosine analogs acting as RNA polymerase inhibitors
Remdesivir
Get full access now